A wide variety of proteins in neuronal, endocrine and immune tissues undergo proteolytic processing. Many of these proteins and peptides are intercellular messengers. Most neuroendocrine peptides are synthesized from precursor proteins. Post-translational processing of these precursors is a key step in the production of biologically active peptides. In the majority of cases this occurs by proteolysis of the precursors at 'classical'cleavage sites involving endopeptidases of the subtilisin family. A subset of bioactive peptides are generated by processing at 'non-classical'cleavage sites;the protease(s) responsible for these cleavages have not been well explored. Members of the metalloendoprotease family are thought to be involved in non- classical processing. Among them, endothelin converting enzyme-2 (ECE-2) is a good candidate since it exhibits functional properties that are consistent with it being a neuropeptide biosynthetic enzyme. In this grant application we propose to examine the hypothesis that """"""""ECE-2 is neuropeptide processing enzyme that generates novel bioactive peptides by non-classical processing"""""""".
The specific aims are, (i) to characterize the biochemical and enzymological properties of ECE-2, (ii) to study the behavioral phenotype of animals lacking ECE-2 including addictive behaviors, and (iii) to examine the peptide profile in mice lacking ECE-2 using differential isotopic labeling and mass spectrometry. These studies are synergistic and will expand our current knowledge of neuropeptide processing by providing information about novel neuropeptides. Furthermore, findings from these studies will form a basis for future research exploring the functions of these novel neuropeptides in vivo. Since a variety of neuropeptides are involved in normal functioning of the brain, understanding the mechanisms that regulate their endogenous levels becomes a prerequisite to the development of strategies for the treatment of a variety of pathologies including neurodegenerative disorders and drug addiction.
This proposal describes studies on endothelin converting enzyme-2 - a peptide processing enzyme shown to be involved in a number of disorders including drug addiction and Alzheimer's disease. The findings from the proposed studies would help in the development of novel therapeutics for the treatment of these and other neuroendocrine disorders.
|Fricker, Lloyd D; Devi, Lakshmi A (2018) Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther 185:26-33|
|Lueptow, Lindsay M; Devi, Lakshmi A; Fakira, Amanda K (2018) Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Prog Mol Biol Transl Sci 159:1-25|
|Heimann, Andrea S; Gupta, Achla; Gomes, Ivone et al. (2017) Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. PLoS One 12:e0187306|
|Bobeck, Erin N; Gomes, Ivone; Pena, Darlene et al. (2017) The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning. Neuropsychopharmacology 42:2527-2536|
|Reckziegel, Patrícia; Festuccia, William T; Britto, Luiz R G et al. (2017) A novel peptide that improves metabolic parameters without adverse central nervous system effects. Sci Rep 7:14781|
|Pena, Darlene Aparecida; Andrade, Victor Piana de; Silva, Gabriela Ávila Fernandes et al. (2016) Rational design and validation of an anti-protein kinase C active-state specific antibody based on conformational changes. Sci Rep 6:22114|
|Gomes, Ivone; Sierra, Salvador; Devi, Lakshmi A (2016) Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Curr Protoc Pharmacol 75:2.16.1-2.16.31|
|Gomes, Ivone; Bobeck, Erin N; Margolis, Elyssa B et al. (2016) Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci Signal 9:ra43|
|Wardman, Jonathan H; Gomes, Ivone; Bobeck, Erin N et al. (2016) Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Sci Signal 9:ra55|
|Gupta, Achla; Gomes, Ivone; Bobeck, Erin N et al. (2016) Collybolide is a novel biased agonist of ?-opioid receptors with potent antipruritic activity. Proc Natl Acad Sci U S A 113:6041-6|
Showing the most recent 10 out of 37 publications